Volume 11 Issue 3
May  2020
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(3): 400-404
Lin Jun, Li Shixin, Yang Yang. Interpretation of Guide to the Quality and Safety of Organs for Transplantation(6th edition): risk of malignant tumor transmission[J]. ORGAN TRANSPLANTATION, 2020, 11(3): 400-404. doi: 10.3969/j.issn.1674-7445.2020.03.014
Citation: Lin Jun, Li Shixin, Yang Yang. Interpretation of Guide to the Quality and Safety of Organs for Transplantation(6th edition): risk of malignant tumor transmission[J]. ORGAN TRANSPLANTATION, 2020, 11(3): 400-404. doi: 10.3969/j.issn.1674-7445.2020.03.014
shu

Interpretation of Guide to the Quality and Safety of Organs for Transplantation(6th edition): risk of malignant tumor transmission

doi: 10.3969/j.issn.1674-7445.2020.03.014

  • Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

More Information
  • Corresponding author: Lin Jun, E-mail:13601355682@163.com
  • Received Date: 2020-02-09
    Available Online: 2021-01-19
  • Publish Date: 2020-05-15
    Abstract
  • As China enters the era of organ donation after the citizen's death, the organ donation cases with potential malignant tumor history increase gradually. Guide to the Quality and Safety of Organs for Transplantation (6th Edition) by European Committee was translated into Chinese in 2019. This article interprets Chapter 9 of the guideline "Risk of Malignant Tumor Transmission" to assist organ donation coordinator and transplant team in screening donors at risk of malignant tumor transmission in our country and to reduce the risk of donor-derived tumor transmission.

     

    • FullText(HTML)
  • loading
    • References(26)
  • [1]
    ISON MG, NALESNIK MA. An update on donor-derived disease transmission in organ transplantation[J]. Am J Transplant, 2011, 11(6):1123-1130. DOI: 10.1111/j.1600-6143.2011.03493.x.
    [2]
    DESAI R, COLLETT D, WATSON CJ, et al. Cancer transmission from organ donors-unavoidable but low risk[J]. Transplantation, 2012, 94(12):1200-1207. DOI: 10.1097/TP.0b013e318272df41.
    [3]
    NALESNIK MA, WOODLE ES, DIMAIO JM, et al. Donor‐transmitted malignancies in organ transplantation: assessment of clinical risk[J]. Am J Transplant, 2011, 11(6): 1140-1147. DOI: 10.1111/j.1600-6143.2011.03565.x.
    [4]
    GREEN M, COVINGTON S, TARANTO S, et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee[J]. Transplantation, 2015, 99(2): 282-287. DOI: 10.1097/TP.0000000000000584.
    [5]
    SaBTO (The Advisory Committee on the Safety of Blood, Tissues and Organs). Transplantation of organs from deceased donors with cancer or a history of cancer[EB/OL]. (2014-04-01). https://www.odt.nhs.uk/transplantation/tools-policies-and-guidance/sabto/.
    [6]
    European Committee (Partial Agreement) on Organ Transplantation (CD-P-TO) EDQM[M].移植器官质量与安全指南(原书第6版).张雷, 译.北京: 科学出版社, 2019.
    [7]
    ECCHER A, CIMA L, CIANGHEROTTI A, et al. Rapid screening for malignancy in organ donors: 15-year experience with the Verona "Alert" protocol and review of the literature[J]. Clin Transplant, 2017, 31(9). DOI: 10.1111/ctr.13045.
    [8]
    KALIKI S, SHIELDS CL. Uveal melanoma: relatively rare but deadly cancer[J]. Eye (Lond), 2017, 31(2):241-257. DOI: 10.1038/eye.2016.275.
    [9]
    ECCHER A, LOMBARDINI L, GIROLAMI I, et al. How safe are organs from deceased donors with neoplasia? the results of the Italian Transplantation Network[J]. J Nephrol, 2019, 32(2): 323-330. DOI: 10.1007/s40620-018-00573-z.
    [10]
    VAN ERP AC, VAN DULLEMEN LFA, PLOEG RJ, et al. Systematic review on the treatment of deceased organ donors[J]. Transplant Rev (Orlando), 2018, 32(4):194-206. DOI: 10.1016/j.trre.2018.06.001.
    [11]
    MILLER AK, YOUNG JW, WILSON DJ, et al. Transmission of donor-derived breast carcinoma as a recurrent mass in a keratolimbal allograft[J]. Cornea, 2017, 36(6):736-739. DOI: 10.1097/ICO. 0000000000001185.
    [12]
    XIAO D, CRAIG JC, CHAPMAN JR, et al. Donor cancer transmission in kidney transplantation: a systematic review[J]. Am J Transplant, 2013, 13(10): 2645-2652. DOI: 10.1111/ajt.12430.
    [13]
    WILLIAMS T, ALJITAWI OS, MOUSSA R, et al. First case of donor transmitted non-leukemic promyelocytic sarcoma[J]. Leuk Lymphoma, 2012, 53(12): 2530-2534. DOI: 10.3109/10428194.2012.695360.
    [14]
    XIE L, ZHOU F. Development of lymphoma from the donor of haploidentical stem cell transplantation: a case report[J]. Mol Clin Oncol, 2017, 7(5): 851-854. DOI: 10.3892/mco.2017.1414.
    [15]
    DZIEWANOWSKI K, DROZD R, PARCZEWSKI, M et al. Multiorgan transplantation from a deceased donor with intravascular diffuse large B-cell lymphoma: transmission of the disease and results of treatment[J]. Clin Transplant, 2014, 28(10):1080-1083. DOI: 10.1111/ctr.12417.
    [16]
    CASSOL CA, HOD-DVORAI R, HUBBELL C, et al. Donor-derived philadelphia chromosome positive B-cell lymphoblastic leukemia presenting with renal allograft involvement in the first year post-transplant[J]. Am J Transplant, 2019, 19(3):956-957. DOI: 10.1111/ajt.15117.
    [17]
    TOFFALORI C, ZITO L, GAMBACORTA V, et al. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation [J]. Nat Med, 2019, 25(4):603-611. DOI: 10.1038/s41591-019-0400-z.
    [18]
    SOSIN M, NASSIF SR, GIRLANDA R, et al. Isolated peritoneal donor-related plasmacytoma 3 years after liver transplantation: a case report[J]. Am J Transplant, 2014, 14(2):472-476. DOI: 10.1111/ajt.12555.
    [19]
    ARBER DA, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20):2391-2405. DOI: 10.1182/blood-2016-03-643544.
    [20]
    GRINFELD J, NANGALIA J, BAXTER EJ, et al. Classification and personalized prognosis in myeloproliferative neoplasms[J]. N Engl J Med, 2018, 379(15): 1416-1430. DOI: 10.1056/NEJMoa1716614.
    [21]
    BARBUI T, BAROSI G, BIRGEGARD G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet[J]. J Clin Oncol, 2011, 29(6):761-770. DOI: 10.1200/JCO.2010.31.8436.
    [22]
    WATSON C, ROBERTS R, WRIGHT K, et al. How safe is it to transplant organs from deceased donors with primary intracranial malignancy? an analysis of UK registry data[J]. Am J Transplant, 2010, 10(6): 1437-1444. DOI: 10.1111/j.1600-6143.2010.03130.x.
    [23]
    ZHAO P, STROHL A, GONZALEZ C, et al. Donor transmission of pineoblastoma in a two‐yr‐old male recipient of a multivisceral transplant: a case report[J]. Pediatr Transplant, 2012, 16(4): E110-E114. DOI: 10.1111/j.1399-3046.2010.01463.x.
    [24]
    CAVALIERE R, SCHIFF D. Donor transmission of primary brain tumors: a neurooncologic perspective[J]. Transpl Rev, 2004, 18(4): 204-213. DOI: 10.1016/j.trre.2004.09.003.
    [25]
    HYNES CF, RAMAKRISHNAN K, ALFARES FA, et al. Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm—a UNOS database study[J]. Clin Transplant, 2017, 31(4). DOI: 10.1111/ctr.12919.
    [26]
    LOUIS DN, PERRY A, REIFENBERGER G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6):803-820. DOI: 10.1007/s00401-016-1545-1.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (447) PDF downloads(33) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return